BusinessVCANBIO USA and VCANBIO Center for Translational Biotechnology Launch in the United StatesBy Nasdaq OMXSep 8, 2016, 12:01 PM UTC
BusinessVCANBIO USA and VCANBIO Center for Translational Biotechnology Launch in the United StatesBy Nasdaq OMXSep 8, 2016, 12:01 PM UTC
BusinessAdaptimmune Announces FDA Acceptance of IND Application for Affinity Enhanced T-Cell Therapy Targeting AFP in Liver CancerBy Nasdaq OMXApr 7, 2016, 1:03 PM UTC
BusinessU.S. Food and Drug Administration Grants Orphan Drug Designation to Adaptimmune’s T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue SarcomaBy Nasdaq OMXMar 30, 2016, 11:40 AM UTC
BusinessAdaptimmune Reports Financial Results for the Six-Month Period ended December 31, 2015By Nasdaq OMXMar 17, 2016, 11:56 AM UTC
BusinessCesca Therapeutics to Announce Second Quarter Fiscal 2016 Results and Provide a Status Update to Investors on February 16, 2016By Nasdaq OMXFeb 11, 2016, 11:00 AM UTC
BusinessAdaptimmune to Host Conference Call at 10:00 AM ET (3:00 PM GMT) Today (Tuesday, February 2) to Discuss Expansion of Strategic Collaboration Agreement with GlaxoSmithKline (GSK)By Nasdaq OMXFeb 2, 2016, 1:21 PM UTC
BusinessAdaptimmune and GSK Expand Strategic Immunotherapy CollaborationBy Nasdaq OMXFeb 2, 2016, 1:16 PM UTC
